VTE pathways, clinics and prescribing
Patient pathways, independent prescribing by pharmacists and education of junior doctors all contribute to the effective operation of the VTE service, according to Mr Kieron Power; Lead Pharmacist… read more.
Patient pathways, independent prescribing by pharmacists and education of junior doctors all contribute to the effective operation of the VTE service, according to Mr Kieron Power; Lead Pharmacist… read more.
Recurrence of venous thrombo-embolism (VTE) may be more common than people think and 30% of people develop post thrombotic syndrome, according to Mr Kieron Power; Lead Pharmacist –… read more.
Specialist pharmacists are now the primary clinicians who look after patients with venous thromboembolism (VTE) at Singleton Hospital in Swansea. IMI spoke to Mr Kieron Power, Clinical Lead… read more.
Novartis welcomed the news that the National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination recommending Rydapt (midostaurin) for the treatment of aggressive… read more.
Moderately ill patients hospitalized with COVID-19 have achieved a better rate of respiratory organ support-free days and survival if treated with therapeutic-dose anticoagulation, researchers reported on August 20,2021… read more.
A new study from the University of California, Irvine shows that compounds in both green and black tea relax blood vessels by activating ion channel proteins in the… read more.
Genentech, a member of the Roche Group announced results from the final analysis of the Phase IIIb STASEY study , which confirm the favorable safety profile of Hemlibra… read more.
Hypertension, or high blood pressure, kills more Americans than any other health condition. It is especially prevalent in Black Americans and is exacerbated by structural barriers to accessing… read more.
Novartis announced that Entresto (sacubitril/valsartan) has received a new indication in China for the treatment of patients with essential hypertension, a disease affecting approximately 245 million adults in… read more.
A “prescription” to sit less and move more is the optimal first treatment choice for reducing mild to moderately elevated blood pressure and blood cholesterol in otherwise healthy… read more.
Long-term data gathered from wearables can quicky indicate illness and other abnormalities in a patient’s health. DURHAM, N.C. — Smartwatches and other wearable devices may be used to… read more.
Bristol Myers Squibb has announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Onureg (azacitidine tablets; CC-486) as a… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.